首页> 外文期刊>BMC Public Health >A study protocol for a randomised controlled trial evaluating the use of information communication technology (WhatsApp/WeChat) to deliver brief motivational interviewing (i-BMI) in promoting smoking cessation among smokers with chronic diseases
【24h】

A study protocol for a randomised controlled trial evaluating the use of information communication technology (WhatsApp/WeChat) to deliver brief motivational interviewing (i-BMI) in promoting smoking cessation among smokers with chronic diseases

机译:用于随机对照试验的研究方案,评估信息通信技术(Whatsapp / Wechat)提供短暂的励志访谈(I-BMI)在促进慢性疾病的吸烟者中促进吸烟戒烟

获取原文
           

摘要

The recent development of smoking cessation interventions for smokers with chronic diseases has focused heavily on brief interventions. However, these interventions are too brief to make an impact on these smokers, especially when most of them are without any intention to quit. Previous studies showed that smokers who did not want to quit might be interested in changing other health behaviours. Also, once people engage in a health behaviour, they are found more likely to change other unhealthy habits. Hence, a general health promotion approach could be a feasible approach to motivate smokers who do not want to quit to first engage in any desirable health behaviour, and later quit smoking when they intend to do so. This study aims to determine the potential efficacy and effect size of such intervention approach in promoting smoking cessation for smokers with chronic diseases. This is a randomized controlled trial. A convenience sample of 60 smokers with chronic diseases will be randomly assigned into either experimental (n?=?30) or control group (n?=?30). Smokers in the experimental group will receive an individual face-to-face brief motivational interviewing (MI) with generic advice on selected health behaviour. More brief MI messages will be delivered to them via WhatsApp/WeChat for 6?months. For subject in the control group, they will be asked to indicate their desirable health-related practice. However, no MI and booster interventions will be given. All subjects will complete a questionnaire at 1, 3, 6 and 12?months. Subjects abstinent from cigarettes at 12?months will perform a biochemical validation. The primary outcome is biochemically validated smoking abstinence at 12?months. Effect size of the intervention will be estimated by the odd ratios using intention-to-treat. This is the first study to determine the potential efficacy for the use of a personalized general health promotion approach in promoting smoking cessation for smokers with chronic diseases. If our proposed intervention is effective, we will able to assist smokers with chronic disease to quit smoking and change their health behaviour simultaneously. CinicalTrials.gov NCT03983330 (Prospectively registered), registered on June 12, 2019.
机译:最近对慢性病患者的吸烟干预措施的发展已经严重关注简要的干预措施。然而,这些干预措施对于这些吸烟者来说太简短,特别是当他们中的大多数没有任何意图戒烟时。以前的研究表明,不想退出的吸烟者可能有兴趣改变其他健康行为。此外,一旦人们从事健康行为,他们被发现更有可能改变其他不健康的习惯。因此,一般健康促进方法可能是一种可行的方法,可以激励不想放弃任何理想的健康行为的吸烟者,后来在他们打算这样做时戒烟。本研究旨在确定这种干预方法的潜在疗效和效果规模,促进慢性疾病吸烟的吸烟。这是一个随机对照试验。 60个吸烟者的便利样品将随机分配到实验(N?= 30)或对照组(N?= 30)中。实验组吸烟者将收到个人面对面的简短励志访谈(MI),具有关于所选健康行为的通用建议。更多简要的MI消息将通过WhatsApp / Wechat向他们发送6?几个月。对于对照组的主题,将要求他们表明他们有效的健康状况。但是,否则不会给出MI和助推器干预措施。所有受试者将在1,3,6和12个月内完成调查问卷。几个月。从12月12日从香烟造成的受试者将进行生化验证。主要结果是生物化学验证的吸烟戒烟在12?月份。使用意向治疗的奇数比率估算干预的效果大小。这是第一项研究,以确定利用个性化的一般健康促进方法促进吸烟者吸烟的潜在疗效的研究。如果我们的拟议干预是有效的,我们将能够帮助吸烟者患有慢性病,以戒烟并同时改变健康行为。 CinicalTrials.gov NCT03983330(预期注册),2019年6月12日注册。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号